ArticleClinical, cosmetic and investigational dermatology2024

Secukinumab for Severe Hidradenitis Suppurativa in a Patient on Haemodialysis: Efficacy and Safety on 300 mg Every 2 Weeks Administration - A Case Report.

Fabrizio Martora et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.